• C Pai Foundational Biomedical Sciences Dept., Touro University College of Osteopathic Medicine, California, USA
  • JJ Larion Touro University College of Osteopathic Medicine, California



Ventilator Associated Pneumonia (VAP), COVID-19, ARDS, Multidrug resistant microbes


Ventilator-associated pneumonia has been a well-known complication in the intensive care unit (ICU) and continues to be a real threat in patients infected with coronavirus disease (COVID- 19), particularly in those that progress to acute respiratory distress syndrome (ARDS) with subsequent mechanical ventilation. Through a global perspective, this descriptive study was aimed at describing the patterns of co-infection with ventilator-associated pneumonia (VAP) in patients with COVID-19 ARDS. The global incidence rate of VAP in COVID-19 patients on mechanical ventilation was determined to be 41.2% supported by extended time spent on mechanical ventilation, increase in mortality rate, and the emergence of drug-resistant microbes. These outcomes are accompanied by the concomitant presence of previous antimicrobial use, invasive respiratory operations due to COVID-19 ARDS, and in some cases, corticosteroid treatment. The results of our findings add to the emergent threat of VAP as an important nosocomial infection as the COVID-19 pandemic persists.


Download data is not yet available.

Author Biography

JJ Larion, Touro University College of Osteopathic Medicine, California

1st year Student, Touro University College of Osteopathic Medicine, California


Agrafiotis, M., Siempos, I. I., Ntaidou, T. K., & Falagas, M. E. (2011). Attributable mortality of ventilator-associated pneumonia: A meta-analysis. The International Journal of Tuberculosis and Lung Disease, 15(9), 1154–1163, i.

American Thoracic Society, & Infectious Diseases Society of America. (2005). Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal of Respiratory and Critical Care Medicine, 171(4), 388–416.

Aslan, A., Aslan, C., Zolbanin, N. M., & Jafari, R. (2021). Acute respiratory distress syndrome in COVID-19: Possible mechanisms and therapeutic management. Pneumonia (Nathan Qld.), 13(1), 14.

Baccolini, V., Migliara, G., Isonne, C., Dorelli, B., Barone, L. C., Giannini, D., … Villari, P. (2021). The impact of the COVID-19 pandemic on healthcare-associated infections in intensive care unit patients: A retrospective cohort study. Antimicrobial Resistance and Infection Control, 10(1), 87.

Bardi, T., Pintado, V., Gomez-Rojo, M., Escudero-Sanchez, R., Azzam Lopez, A., Diez-Remesal, Y., … Pestaña, D. (2021). Nosocomial infections associated to COVID-19 in the intensive care unit: Clinical characteristics and outcome. European Journal of Clinical Microbiology & Infectious Diseases, 40(3), 495–502.

Blonz, G., Kouatchet, A., Chudeau, N., Pontis, E., Lorber, J., Lemeur, A., … Colin, G. (2021). Epidemiology and microbiology of ventilator-associated pneumonia in COVID-19 patients: A multicenter retrospective study in 188 patients in an un-inundated French region. Critical Care, 25(1), 72.

Bolker, A., Coe, K., Smith, J., Stevenson, K., Wang, S.-H., & Reed, E. (2022). Predictors of respiratory bacterial co-infection in hospitalized COVID-19 patients. Diagnostic Microbiology and Infectious Disease, 102(1), 115558.

Boyd, S., Nseir, S., Rodriguez, A., & Martin-Loeches, I. (2022). Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review. ERJ open research, 8(3).

Bychinin, M. V., Antonov, I. O., Klypa, T. V., Mandel, I. A., Minets, A. I., Kolyshkina, N. A., & Golobokova, Ya. B. (2022). Nosocomial Infection in Patients with Severe and Critical COVID-19. General Reanimatology, 18(1), 4–10.

Carbonell, R., Urgelés, S., Rodríguez, A., Bodí, M., Martín-Loeches, I., Solé-Violán, J., … COVID-19 SEMICYUC Working Group. (2021). Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study. The Lancet Regional Health. Europe, 11, 100243.

Castañeda-Méndez, P., Cabrera-Ruiz, M. L., Barragán-Reyes, A., Aguilar, E. A., Sanchez, B. A., Salgado, M. F. R., … Frias, L. (2021). 388. Epidemiologic and microbiologic characteristics of hospital-acquired infections in patients with COVID-19 at intensive care unit, Mexico City. Open Forum Infectious Diseases, 8(Supplement_1), S296–S296.

Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., … Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513.

Cohen, R., Babushkin, F., Finn, T., Geller, K., Alexander, H., Datnow, C., … Lellouche, J. (2021). High rates of bacterial pulmonary co-infections and superinfections identified by multiplex PCR among critically ill COVID-19 patients. Microorganisms, 9(12).

Costa, R. L. da, Lamas, C. da C., Simvoulidis, L. F. N., Espanha, C. A., Moreira, L. P. M., Bonancim, R. A. B., … Oliveira, L. P. de. (2022). Secondary infections in a cohort of patients with COVID-19 admitted to an intensive care unit: Impact of gram-negative bacterial resistance. Revista Do Instituto de Medicina Tropical de Sao Paulo, 64, e6.

COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. (2021). Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: A prospective cohort study. Intensive Care Medicine, 47(1), 60–73.

De Santis, V., Corona, A., Vitale, D., Nencini, C., Potalivo, A., Prete, A., … Singer, M. (2022). Bacterial infections in critically ill patients with SARS-2-COVID-19 infection: Results of a prospective observational multicenter study. Infection, 50(1), 139–148.

Dudoignon, E., Caméléna, F., Deniau, B., Habay, A., Coutrot, M., Ressaire, Q., … Dépret, F. (2021). Bacterial pneumonia in COVID-19 critically ill patients: A case series. Clinical Infectious Diseases, 72(5), 905–906.

Ferré, A., Marquion, F., Delord, M., Gros, A., Lacave, G., Laurent, V., … RESPI-COVID19 Study Group. (2022). Association of ventilator type with hospital mortality in critically ill patients with SARS-CoV2 infection: A prospective study. Annals of Intensive Care, 12(1), 10.

Gamberini, L., Tonetti, T., Spadaro, S., Zani, G., Mazzoli, C. A., Capozzi, C., … ICU-RER COVID-19 Collaboration. (2020). Factors influencing liberation from mechanical ventilation in coronavirus disease 2019: Multicenter observational study in fifteen Italian ICUs. Journal of Intensive Care, 8, 80.

Gangneux, J.-P., Dannaoui, E., Fekkar, A., Luyt, C.-E., Botterel, F., De Prost, N., … Bougnoux, M.-E. (2022). Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: The French multicentre MYCOVID study. The Lancet. Respiratory Medicine, 10(2), 180–190.

Gao, Y.-D., Ding, M., Dong, X., Zhang, J.-J., Kursat Azkur, A., Azkur, D., … Akdis, C. A. (2021). Risk factors for severe and critically ill COVID-19 patients: A review. Allergy, 76(2), 428–455.

Giacobbe, D. R., Battaglini, D., Enrile, E. M., Dentone, C., Vena, A., Robba, C., … Bassetti, M. (2021). Incidence and prognosis of ventilator-associated pneumonia in critically ill patients with COVID-19: A multicenter study. Journal of Clinical Medicine, 10(4).

Grasselli, G., Scaravilli, V., Mangioni, D., Scudeller, L., Alagna, L., Bartoletti, M., … Bandera, A. (2021). Hospital-acquired infections in critically ill patients with COVID-19. Chest, 160(2), 454–465.

Han, J., & Liu, Y. (2010). Effect of ventilator circuit changes on ventilator-associated pneumonia: a systematic review and meta-analysis. Respiratory Care, 55(4), 467-474.

Isac, C., Samson, H. R., & John, A. (2021, October). Prevention of VAP: endless evolving evidences–systematic literature review. In Nursing Forum (Vol. 56, No. 4, pp. 905-915).

Jamnani, A. N., Montazeri, M., Mirzakhani, M., Moosazadeh, M., & Haghighi, M. (2022). Evaluation of bacterial coinfection and antibiotic resistance in patients with COVID-19 under mechanical ventilation. SN Comprehensive Clinical Medicine, 4(1), 19.

Kalil, A. C., Metersky, M. L., Klompas, M., Muscedere, J., Sweeney, D. A., Palmer, L. B., … Brozek, J. L. (2016). Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 Clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases, 63(5), e61–e111.

Kohbodi, G. A., Rajasurya, V., & Noor, A. (2022). Ventilator-associated pneumonia. In StatPearls. Treasure Island (FL): StatPearls Publishing.

Kundu, R., & Singla, N. (2022). COVID-19 and Plethora of Fungal Infections. Current Fungal Infection Reports, 1–8.

Luque-Paz, D., Tattevin, P., Jaubert, P., Reizine, F., Kouatchet, A., & Camus, C. (2022). Selective digestive decontamination to reduce the high rate of ventilator-associated pneumonia in critical COVID-19. Anaesthesia Critical Care & Pain Medicine, 41(1), 100987.

Luyt, C.-E., Sahnoun, T., Gautier, M., Vidal, P., Burrel, S., Pineton de Chambrun, M., … Chastre, J. (2020). Ventilator-associated pneumonia in patients with SARS-CoV-2-associated acute respiratory distress syndrome requiring ECMO: A retrospective cohort study. Annals of Intensive Care, 10(1), 158.

Maes, M., Higginson, E., Pereira-Dias, J., Curran, M. D., Parmar, S., Khokhar, F., … Conway Morris, A. (2021). Ventilator-associated pneumonia in critically ill patients with COVID-19. Critical Care, 25(1), 25.

Meawed, T. E., Ahmed, S. M., Mowafy, S. M. S., Samir, G. M., & Anis, R. H. (2021). Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. Journal of Infection and Public Health, 14(10), 1375–1380.

Moretti, M., Van Laethem, J., Minini, A., Pierard, D., & Malbrain, M. L. N. G. (2021). Ventilator-associated bacterial pneumonia in coronavirus 2019 disease, a retrospective monocentric cohort study. Journal of Infection and Chemotherapy, 27(6), 826–833.

National Healthcare Safety Network. (2022). Pneumonia (ventilator-associated [VAP] and non-ventilator associated pneumonia [PNEU]) . Retrieved from

Ong, C. C. H., Farhanah, S., Linn, K. Z., Tang, Y. W., Poon, C. Y., Lim, A. Y., … Marimuthu, K. (2021). Nosocomial infections among COVID-19 patients: an analysis of intensive care unit surveillance data. Antimicrobial Resistance and Infection Control, 10(1), 119.

Page, McKenzie, Bossuyt, Boutron, Hoffmann, Mulrow, C. D., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ (Clinical Research Ed.), 372, n71.

Papamanoli, A., Nakamura, J., Fung, J., Abata, J., Karkala, N., Tsui, S. T., … Marcos, L. (2020). 382. Incidence of hospital-acquired and ventilator-associated pneumonia in patients with severe COVID 19 on high flow oxygen. Open Forum Infectious Diseases, 7(Supplement_1), S260–S261.

Pickens, C. O., Gao, C. A., Cuttica, M. J., Smith, S. B., Pesce, L. L., Grant, R. A., … NU COVID Investigators. (2021). Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. American Journal of Respiratory and Critical Care Medicine, 204(8), 921–932.

Ragab, D., Salah Eldin, H., Taeimah, M., Khattab, R., & Salem, R. (2020). The COVID-19 cytokine storm; what we know so far. Frontiers in Immunology, 11, 1446.

Razazi, K., Arrestier, R., Haudebourg, A. F., Benelli, B., Carteaux, G., Decousser, J.-W., … Mekontso Dessap, A. (2020). Risks of ventilator-associated pneumonia and invasive pulmonary aspergillosis in patients with viral acute respiratory distress syndrome related or not to Coronavirus 19 disease. Critical Care, 24(1), 699.

Risa, E., Roach, D., Budak, J. Z., Hebert, C., Chan, J. D., Mani, N. S., … Johnson, N. J. (2021). Characterization of secondary bacterial infections and antibiotic use in mechanically ventilated patients with COVID-19 induced acute respiratory distress syndrome. Journal of Intensive Care Medicine, 36(10), 1167–1175.

Roger, C., Collange, O., Mezzarobba, M., Abou-Arab, O., Teule, L., Garnier, M., … AZUREA group. (2021). French multicentre observational study on SARS-CoV-2 infections intensive care initial management: The FRENCH CORONA study. Anaesthesia Critical Care & Pain Medicine, 40(4), 100931.

Rojas-Fermin, R. A., Guzman, A. E., Sanchez, A., Germosen, E., Matos, C., & Mena Lora, A. J. (2021). 406. Incidence of community and hospital acquired infections in critically ill COVID-19 patients in the Dominican Republic. Open Forum Infectious Diseases, 8(Supplement_1), S304–S305.

Rouyer, M., Strazzulla, A., Youbong, T., Tarteret, P., Pitsch, A., de Pontfarcy, A., … Diamantis, S. (2021). Ventilator-associated pneumonia in COVID-19 patients: A retrospective cohort study. Antibiotics (Basel, Switzerland), 10(8).

Rouzé, A., Martin-Loeches, I., Povoa, P., Makris, D., Artigas, A., Bouchereau, M., … coVAPid study Group. (2021). Relationship between SARS-CoV-2 infection and the incidence of ventilator-associated lower respiratory tract infections: A European multicenter cohort study. Intensive Care Medicine, 47(2), 188–198.

Sharifipour, E., Shams, S., Esmkhani, M., Khodadadi, J., Fotouhi-Ardakani, R., Koohpaei, A., … Ej

Golzari, S. (2020). Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU. BMC Infectious Diseases, 20(1), 646.

Søgaard, K. K., Baettig, V., Osthoff, M., Marsch, S., Leuzinger, K., Schweitzer, M., … Egli, A. (2021). Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia. Journal of Intensive Care, 9(1), 10.

Suarez-de-la-Rica, A., Serrano, P., De-la-Oliva, R., Sánchez-Díaz, P., Molinero, P., Falces-Romero, I., … Maseda, E. (2021). Secondary infections in mechanically ventilated patients with COVID-19: An overlooked matter? Revista Espanola de Quimioterapia, 34(4), 330–336.

Weinberger, J., Rhee, C., & Klompas, M. (2022). Incidence, characteristics, and outcomes of ventilator-associated events during the COVID-19 pandemic. Annals of the American Thoracic Society, 19(1), 82–89.

Wu, D., Wu, C., Zhang, S., & Zhong, Y. (2019). Risk Factors of ventilator-associated pneumonia in critically iII Patients. Frontiers in Pharmacology, 10, 482.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., … Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet, 395(10229), 1054–1062.




How to Cite

Pai, C., & Larion, J. (2023). THE GLOBAL EMERGENCE OF VENTILATOR-ASSOCIATED PNEUMONIA (VAP) IN THE ERA OF THE COVID-19 PANDEMIC: A DESCRIPTIVE STUDY. Proceedings of the Global Public Health Conference, 6(1), 89–108.